Institution statistics

SYNAPSE RESEARCH MANAGEMENT PARTNERS SL - Spain 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:400-500
Total Number of Projects:800-900
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2017
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:500-600
Networking Rank (Reputation):300-400
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 21
As coordinator: 1
As participant: 20
Sole participant: 0
Coordinator / Participant Ratio: 0.05*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 89.815.600 1.677.500 1
2019 1.199.125 35.645.725 3.053.063 1 3
2018 0 18.604.681 1.417.875 2
2017 0 71.697.938 5.282.325 5
2016 0 15.998.136 746.500 2
2015 0 3.463.481 275.250 1
2014 0 7.492.000 540.952 2
2013 0 5.984.720 308.800 1
2011 0 2.997.196 264.896 1
2010 0 2.748.319 80.586 1
2008 0 11.889.367 516.929 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
JANSSEN PHARMACEUTICA NV12
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM11
NOVARTIS PHARMA7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
ELI LILLY AND COMPANY LIMITED6
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE6
ASTRAZENECA AB5
F HOFFMANNLA ROCHE5
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER5
PFIZER LIMITED5
ALZHEIMER EUROPE4
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM4
THE UNIVERSITY OF EDINBURGH4
UNIVERSITY OF NEWCASTLE UPON TYNE4
ABBVIE INC3
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS3
BAYER AKTIENGESELLSCHAFT3
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
EUROPEAN PATIENTS' FORUM3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
SANOFIAVENTIS3
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT3
ST GEORGE'S HOSPITAL MEDICAL SCHOOL3
TAKEDA DEVELOPMENT CENTRE EUROPE3
THE UNIVERSITY OF LIVERPOOL3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY OF HELSINKI3
ACADEMISCH ZIEKENHUIS GRONINGEN2
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS2
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG2
CELGENE MANAGEMENT SARL2
CERTARA UK LIMITED2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
DRUG SAFETY RESEARCH TRUST2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION2
FONDAZIONE SCIENTIFICA SIMGONLUS2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
GE HEALTHCARE LIMITED2
GLAXOSMITHKLINE BIOLOGICALS2
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT2
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION2
H LUNDBECK AS2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
IXICO TECHNOLOGIES LIMITED2
KAROLINSKA INSTITUTE2
KLINIKUM DER UNIVERSITAET ZU KOELN2
LEIBNIZINSTITUT FUER PRAEVENTIONSFORSCHUNG UND EPIDEMIOLOGIE BIPS2
LUNDS UNIVERSITET2
MEDIZINISCHE UNIVERSITAET WIEN2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
MERCK SHARP & DOHME CORP2
NOVO NORDISK2
OSPEDALE PEDIATRICO BAMBINO GESU2
PHARMO INSTITUTE NV2
SANOFI PASTEUR2
SERVICIO MADRILENO DE SALUD2
STICHTING INFORMATIEVOORZIENING VOOR ZORG EN ONDERZOEK2
STICHTING VU2
STICHTING VUMC2
TARTU ULIKOOL2
THE UNIVERSITY OF MANCHESTER2
UCB BIOPHARMA2
UNIVERSIDADE DE AVEIRO2
UNIVERSITAET BREMEN2
UNIVERSITAT WIEN2
UNIVERSITEIT LEIDEN2
UNIVERSITY OF BOLOGNA2
UNIVERSITY OF COPENHAGEN2
UNIVERSITY OF YORK2
AARHUS UNIVERSITETSHOSPITAL1
ABBOTT BIOLOGICALS BV1
ABBVIE DEUTSCHLAND GMBH & CO KG1
ABX CRO ADVANCED PHARMACEUTICAL SERVICES FORSCHUNGSGESELLSCHAFT MBH1
AC IMMUNE1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS LEIDEN1
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN1
AGENZIA ITALIANA DEL FARMACO1
ALEXION SERVICES EUROPE SPRL1
ALLERGAN LIMITED1
AMGEN1
AMGEN LIMITED1
ARISTOTLE UNIVERSITY OF THESSALONIKI1
ASPHALION SL1
ASSOCIATION INTERNATIONALE DE STANDARDISATION BIOLOGIQUE POUR L'EUROPE1
ASTRAZENECA1
AVERBIS1
BARTS AND THE LONDON NHS TRUST1
BAYER PHARMA1
BERRY CONSULTANTS LLP1
BILL & MELINDA GATES FOUNDATION1
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE1
BIOBASE1
BIOCOMPUTING PLATFORMS LTD OY1
BIOGEN IDEC LIMITED1
BMD SOFTWARE LDA1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
Constancy:

Total number of partners:425

Partner loyalty:
Frequent Partner: (> 2 projects): 128
Rare Partner: 297

Frequent / Rare Partner Ratio: 0.43

Diversity:

Subjects: Diversity index:0.68
Categories:
Category:No:
BIOLOGICAL SCIENCES5
SOCIAL AND ECONOMIC CONCERNS1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-01-01EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS ERA4TBparticipant89.815.60031
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95336
2019-03-01Efficiently Networking European Neurodegeneration Research NEURONETcoordinator1.199.12510
2019-02-01Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease TransBioLineparticipant13.999.99827
2019-01-01Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe HTxparticipant9.640.77515
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-07-01Development of Robust and Innovative Vaccine Effectiveness DRIVEparticipant8.999.81315
2017-01-01Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 TransQSTparticipant8.000.00023
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
2017-01-01REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 RESCEUparticipant14.498.12518
2016-11-01Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020 ROADMAPparticipant3.998.25026
2016-10-01Amyloid imaging to Prevent Alzheimer’s Disease – Sofia ref.: 115952 AMYPADparticipant11.999.88615
2015-05-01Creating medically-driven integrative bioinformatics applications focused on oncology, CNS disorders and their comorbidities (MedBioinformatics) MedBioinformaticsparticipant3.463.4819
2014-02-01Treatment of late onset bacterial sepsis caused by vancomycin susceptible bacteria in neonates and infants aged under three months NEOVANCparticipant5.993.00012
2014-01-01Semantic Data Platform for Healthcare SEMCAREparticipant1.499.0005
2013-12-01Therapeutic TriMix / mRNA based Vaccine in Chronic HIV-1 Infected Patients Receiving Antiretroviral Therapy IHIVARNAparticipant5.984.7208
2011-10-01Safety Evaluation of Adverse Reactions in Diabetes SAFEGUARDparticipant2.997.19617
2010-01-01Arrhythmogenic potential of drugs ARITMOparticipant2.748.31920
2008-01-01Genotype-to-phenotype databases: A holistic solution GEN2PHENparticipant11.889.36723
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum